IDEXX Q3 Results Reflect Pricing Resilience Despite Lower Vet Visits, UBS Says
UBS said IDEXX Laboratories’ Q3 results reflected its ability to sustain robust pricing despite lower veterinary visits.
Related stories
Gencom Acquires Rosewood London in Its First European Luxury Hotel Deal
The acquisition involves the 308-key hotel.
M impact | EQUITY | Nov 03, 2026, 06:06 PM UTC
IndiGo Expects First Airbus A350 Delivery in Q2 2028
IndiGo expects to receive its first Airbus A350 wide-body aircraft in the second quarter of 2028 as it expands long-haul international operations.
L impact | EQUITY | Nov 03, 2026, 06:04 PM UTC
Aecon Completes $320 Million Purchase of Utilities Preferred Shares
Aecon bought all outstanding Aecon Utilities preferred shares for $320 million in cash, funded from available cash on hand. The transaction had been previously disclosed.
M impact | EQUITY | Nov 03, 2026, 06:03 PM UTC
US session market picture: S&P 500 +0.45%, Nasdaq 100 +0.85%; EUR/USD +0.07%, WTI -0.59%, WBD leads volume
US session market picture. US index futures: S and P futures is up 0.45 percent, Nasdaq futures is up 0.85 percent, Dow futures is down 0.42 percent and Russell futures is up 0.51
M impact | EQUITY | Nov 03, 2026, 06:01 PM UTC
Inszone Insurance Services Acquires Whitman & Samuelson Insurance Services
The acquisition expands Inszone's commercial manufacturing and distribution expertise in Northern California.
M impact | EQUITY | Nov 03, 2026, 06:00 PM UTC
Sysco Says Cyclosporiasis Outbreak Hit Q1 Sales
Sysco said a cyclosporiasis outbreak affected its first-quarter sales.
L impact | EQUITY | Nov 03, 2026, 05:59 PM UTC